Jane Street
PRQR icon

Jane Street’s ProQR Therapeutics PRQR Stock Holding History

Jane Street’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-28,200
Closed -$186K – 10271
2021
Q1 		$186K Buy
+28,200
New +$144K ﹤0.01% 8323

Other funds holding PRQR

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Privium Fund Management
Privium Fund Management Amsterdam, Netherlands $516M AUM 18.66% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Monaco Asset Management
Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return
M28 Capital Management
M28 Capital Management Stamford, Connecticut $36M AUM 11.62% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Jane Street's PRQR Position: Q3 2026 in Review

Jane Street reduced its ProQR Therapeutics (PRQR) stake by 47% in Q3 2026, selling an estimated $401K and leaving 243,439 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #8513.

Jane Street first reported a position in PRQR in Q2 2019 and has held it in 19 quarters since. The position peaked at $846K in Q2 2026. 42 funds tracked by Wall St. Rank hold PRQR as of Q3 2026.

  • Jane Street held 243,439 shares of ProQR Therapeutics worth $404K as of Q3 2026.
  • Jane Street sold 211,665 ProQR Therapeutics shares in Q3 2026, an estimated $401K.
  • ProQR Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #8513 holding.
  • Jane Street first reported a position in ProQR Therapeutics in Q2 2019 and has held it in 19 quarters since.
  • Jane Street's ProQR Therapeutics position peaked at $846K in Q2 2026.
  • 42 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.